Conexeu Sciences Inc. (CNXU)

NASDAQ: CNXU · USD

$2.38

-0.02 (-0.8%)· Recorded snapshot

Market cap	73.4M
Net income (ttm)	-13.6M
EPS (ttm)	-$0.63
Shares out	30.8M
Volume	231,040.907

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -13.6M
EPS (ttm): -$0.63
Market cap: 73.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-332.9

P25 n/aP50 n/aP75 n/a

ROIC-190.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CNXU indicators

Market & fundamental data

Available fields

144

Groups with data

Currency

USD

Showing 144 of 144 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0002066836
Company name	Conexeu Sciences Inc.
Country	United States
Country code	US
CUSIP number	20715F100
Earnings date	2027-02-03
Enterprise value	$71.9M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-07-31
First seen	2026-07-12
Fiscal year end	October
Founded	2022
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US20715F1003
Last earnings date	2026-09-14
Last refreshed	2026-11-04
Last stock split type	Never
Market cap	$73.4M
Market cap category	Micro-Cap
Next earnings date	2027-02-03
Options	No
Price	$2.38
Price currency	USD
Sector	Healthcare
SIC code	3842
Stock price date	2026-11-03
Symbol	CNXU
U.S. state	Nevada
Website	https://www.conexeu.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-26.58%
FCF / EV yield	-14.76%
FCF yield	-14.46%
P/B ratio	11.15x
Price / tangible book value	12.9x
Sector forward P/E	23.32x
Sector P/E	49.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-170.73%
ROCE	-224.32%
ROE	-332.94%
ROIC	-190.88%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-76,229
Depreciation and amortization	$29,942
EBIT	$-13.2M
EBITDA	$-13.2M
EPS	$-0.63
FCF per share	$-0.34
Financing cash flow	$12M
Free cash flow	$-10.6M
Free cash flow minus SBC	$-16.9M
Investing cash flow	$-107,171
Net borrowing	$-92,188
Net cash flow	$1.4M
Net income	$-13.6M
Operating cash flow minus SBC	$-16.8M
Operating income	$-13.2M
Stock-based compensation	$6.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$0.21
Debt / equity	0.08
Long-term assets	$399,758
Long-term liabilities	$33,233
Net cash (debt)	$1.5M
Net cash / market cap	2.07%
Net cash growth	82.98%
Net debt / equity	-0.26
Piotroski F-Score	1
Property, plant and equipment	$145,959
Shareholders' equity	$5.9M
Tangible book value	$5.7M
Tangible book value per share	$0.21
Total assets	$7.2M
Total cash	$2M
Total debt	$453,802
Total liabilities	$1.3M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$6.8M
Current liabilities	$1.3M
Current ratio	5.31
Net working capital	$3.9M
Quick ratio	1.55
Working capital	$5.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-112.91%
Dividend yield	0%
Shareholder yield	-112.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	-0.83%
1M price change	-23.23%
1M total return	-23.23%
1W price change	-19.32%
1W total return	-19.32%
20-day SMA	$3.18
3M price change	-71.36%
3M total return	-71.36%
50-day SMA	$4.18
52-week high	$18.79
52-week high date	2026-06-03
52-week low	$2.23
52-week low date	2026-11-03
All-time high	$18.79
All-time high date	2026-06-03
All-time low	$2.23
All-time low date	2026-11-03
Average true range (ATR)	$0.44
Average volume	406.3K
Beta (1Y)	-0.25
Change from 52-week high	-87.34%
Change from 52-week low	6.73%
Change from all-time high	-87.34%
Change from all-time low	6.73%
Change from open	0%
Day's gap	-0.83%
Dollar volume	$549,877
High price	$2.45
Low price	$2.23
Monthly RSI	0
Open price	$2.38
Position in 52-week range	68.18%
Premarket change	-4.96%
Premarket close	$2.38
Premarket price	$2.26
Premarket volume	1.8K
Previous close	$2.40
Price vs 20-day SMA	-25.2%
Price vs 50-day SMA	-42.99%
Relative volume	0.57
RSI	32.22
Sharpe ratio	-2.15
Sortino ratio	-3.01
Volume	231K
Weekly RSI	23.62

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18M
Float percentage	58.38%
Shares change (QoQ)	31.12%
Shares change (YoY)	112.91%
Shares held by insiders	35.78%
Shares held by institutions	8.11%
Shares outstanding	30.8M
Short % of float	1.65%
Short % of shares	0.96%
Short ratio	1 days

Deeper analysis on CNXU

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CNXU report

Is a complete CNXU research report available?

No complete published report is available for Conexeu Sciences Inc. (CNXU) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Conexeu Sciences Inc. (CNXU)

Price

Financial snapshot

Fair-value bridge

Latest news · CNXU

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CNXU indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CNXU

Frequently asked questions